454
Views
0
CrossRef citations to date
0
Altmetric
Research

The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs

ORCID Icon, , &
Article: 11 | Received 14 Mar 2020, Accepted 28 Dec 2020, Published online: 04 Dec 2023

References

  • Ugalmugale S, Swain R. Global market insights: over-the-counter drugs market share 2019–2025 trends growth report. 2019. https://www.gminsights.com/industry-analysis/over-the-counter-otc-drugs-market.
  • Menshausen S. Germany Trade and Invest Gesellschaft für Außenwirtschaft und Standortmarketing mbH (Hrsg.). Energiewirtschaft 2008 VR China, Köln. 2009.
  • Greer SL. The three faces of European Union health policy: policy, markets, and austerity. Policy Soc. 2014;33(1):13–24.
  • Simoens S. Creating sustainable European health-care systems through the increased use of generic medicines: a policy analysis. J Gener Med. 2010;7(2):131–137.
  • Bongers F, Carradinha H. How to increase patient access to generic medicines in European healthcare systems. EGA Health Economics Committee, European Generic medicines Association. 2009.
  • Fischer KE, Stargardt T. The diffusion of generics after patent expiry in Germany. Eur J Health Econ. 2016;17(8):1027–1040.
  • Bower AB, Grau SL, Taylor VA. Over-the-counter vs prescription medications: are consumer perceptions of the consequences of drug instruction non-compliance different? Int J Consum Stud. 2013;37(2):228–233.
  • Kennedy JG. Over the counter drugs. BMJ (Clinical Research ed). 1996;312(7031):593–594.
  • Italia S, Wolfenstetter SB, Brüske I, Heinrich J, Berdel D, von Berg A, et al. Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background. BMC Public Health. 2017;17(1):904.
  • Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care. 2005;14(4):246.
  • Paris V, Docteur E., Pharmaceutical Pricing and Reimbursement Policies in Germany OECD Health Working Paper No 39. 2008.
  • Creyer EH. Changing a drug from Rx to OTC status: the consumer behavior and public policy implications of switch drugs. J Product Brand Manag. 2001;10(1):52–64.
  • Ventola CL. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? P T. 2011;36(10):669–684.
  • Kohli E, Buller A. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs. South Med J. 2013;106(2):155–160.
  • Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:173.
  • Lee M, King KW, Reid LN. Factors influencing consumers’ attitudinal and behavioral responses to direct-to-consumer and over-the-counter drug advertising. J Health Commun. 2015;20(4):431–444.
  • Grewal D, Compeau LD. Consumer responses to price and its contextual information cues. Rev Mark Res. 2007;3:109–131.
  • Halme M, Linden K, Kääriä K. Patients’ preferences for generic and branded over-the-counter medicines. Patient Patient-Centered Outcomes Res. 2009;2(4):243–255.
  • Droege M, Maniscalco M, Daniel KL, Baldwin HJ. Consumers’ risk perceptions of prescription and over-the-counter medications. J Pharm Technol. 2007;23(3):142–147.
  • Bronnenberg BJ, Dubé J-P, Gentzkow M, Shapiro JM. Do pharmacists buy Bayer? Informed shoppers and the brand premium *. Q J Econ. 2015;130(4):1669–1726.
  • Macit C, Taner N, Mercanoglu G, Mercanoglu F. Brand loyalty as a strategy for the competition with generic drugs: physicians perspective. J Dev Drugs. 2016;5(3):1–5.
  • Anderson RE, Srinivasan SS. E-satisfaction and e-loyalty: a contingency framework. Psychol Mark. 2003;20(2):123–138.
  • Inman JJ, Zeelenberg M. Regret in repeat purchase versus switching decisions: the attenuating role of decision justifiability. J Consum Res. 2002;29(1):116–128.
  • Dursun İ, Kabadayı ET, Alan AK, Sezen B. Store brand purchase intention: effects of risk, quality, familiarity and store brand shelf space. ProcediaSoc Behav Sci. 2011;24:1190–1200.
  • Diehl S, Mueller B, Terlutter R. Consumer responses towards non-prescription and prescription drug advertising in the US and Germany. Int J Advert. 2008;27(1):99–131.
  • Dodds W, Monroe B, Grewal D. Effects of price, brand, and store information on buyers’ product evaluations. J Mark Res. 1991;28(3):307–319.
  • Völckner F. The dual role of price: decomposing consumers’ reactions to price. J Acad Mark Sci. 2008;36(3):359–377.
  • Kavanoor S, Grewal D, Blodgett J. Ads promoting OTC medications: the effect of ad format and credibility on beliefs, attitudes, and purchase intentions. J Bus Res. 1997;40(3):219–227.
  • Bicen P, editor. Consumer perceptions of quality, risk, and value: a conceptual framework. Revolution in marketing: market driving changes; 2015; Cham: Springer International Publishing.
  • Varki S, Colgate M. The role of price perceptions in an integrated model of behavioral intentions. J Serv Res. 2001;3(3):232–240.
  • Morar DD, editor. An overview of the consumer value literature-perceived value, desired value. Proceedings of the International Conference Marketing-from Information to Decision; 2013; Babes Bolyai University: Cluj-Napoca, Romania.
  • Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (1996). 2000;40(3):378–383.
  • Creswell JW. Research design: qualitative and quantitative approaches. Thousand Oaks, California:SAGE Publications, Inc; 1944.
  • Grewal D, Gottlieb J, Mamorstein H. The moderating effects of message framing and source credibility on the price–perceived risk relationship. J Consum Res. 1994;21(1):145–153.
  • Kauppinen-Räisänen H, Owusu Richard A, Abeeku BB. Brand salience of OTC pharmaceuticals through package appearance. Int J Pharm Healthc Mark. 2012;6(3):230–249.
  • Bortz J. Statistikfür Human- und Sozialwissenschaftler. Germany:Springer; 2005.
  • Muijs D. Doing Quantitative Research in Education with SPSS. 2 ed. London: SAGE Publications Ltd 2011 2020/10/01.
  • Creswell JW, Plano CVL. Designing and conducting mixed methods research. Thousand Oaks, California:BMJ Publishing Group; 2011.
  • Lodorfos G, Mulvana K, Temperley J. Consumer behaviour: experience, price, trust and subjective norms in the OTC pharmaceutical market. Innov Mark. 2006;2:41–66.
  • Sinha I, Batra R. The effect of consumer price consciousness on private label purchase. Int J Res Mark. 1999;16(3):237–251.
  • Bowling A. Just one question: If one question works, why ask several? J EpidemiolCommun Health. 2005;59(5):342–345.
  • Koschate-Fischer N, Hoyer WD, Stokburger-Sauer NE, Engling J. Do life events always lead to change in purchase? The mediating role of change in consumer innovativeness, the variety seeking tendency, and price consciousness. J Acad Mark Sci. 2018;46(3):516–536.
  • Stone RN, Grønhaug K. Perceived risk: further considerations for the marketing discipline. Eur J Mark. 1993;27(3):39–50.
  • Dodds W. The effects of perceived and objective market cues on consumers’ product evaluations. Mark Bull. 2002;13(2):1–14.
  • Williams PA, O’Donoghue AC, Sullivan HW, Willoughby JF, Squire C, Parvanta S, et al. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising. Patient EducCouns. 2016;99(4):583–590.
  • Grewal D, Monroe KB, Krishnan R. The effects of price-comparison advertising on buyers’ perceptions of acquisition value, transaction value, and behavioral intentions. J Mark. 1998;62(2):46–59.
  • Alford BL, Biswas A. The effects of discount level, price consciousness and sale proneness on consumers’ price perception and behavioral intention. J Bus Res. 2002;55(9):775–783.
  • Moon J, Chadee D, Tikoo S. Culture, product type, and price influences on consumer purchase intention to buy personalized products online. J Bus Res. 2008;61(1):31–39.
  • Konuk FA. Consumers’ willingness to buy and willingness to pay for fair trade food: the influence of consciousness for fair consumption, environmental concern, trust and innovativeness. Food Res Int. 2019;120:141–147.
  • Pearson K. Notes on regression and inheritance in the case of two parents. Proc R SocLond. 1895;58:240–242.
  • Hayes AF. An index and test of linear moderated mediation. Multivar Behav Res. 2015;50(1):1–22.
  • Hayes AF, Montoya AK, Rockwood NJ. The analysis of mechanisms and their contingencies: PROCESS versus structural equation modeling. Australas Mark J (AMJ). 2017;25(1):76–81.
  • Baron R, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J PersSoc Psychol. 1986;51(6):1173–1182.
  • Naami A, Sheykhaghaee K, Ghanbarzad A. The effect of extrinsic cues of products on brand preference and customer purchase intentions: the moderating effect of social factors. Helix. 2017;8:1171–1177.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
  • Webb NM, Shavelson RJ, Haertel EH. 4 Reliability coefficients and generalizability theory. In: Rao CR, Sinharay S, editors. Handbook of statistics, vol. 26. Elsevier; 2006. p. 81–124.
  • Purohit D, Srivastava J. Effect of manufacturer reputation, retailer reputation, and product warranty on consumer judgments of product quality: a cue diagnosticity framework. J Consum Psychol. 2001;10(3):123–134.
  • Lins Ferreira V, Pereira da Veiga CR, Kudlawicz-Franco C, Scalercio P, Ramires Y, Pontarolo R, et al. Generic drugs in times of economic crisis: are there changes in consumer purchase intention? J Retail Consum Serv. 2017;37:1–7.
  • Sullivan DL, Birdwell SW, Kucukarslan SN. An assessment of consumer purchasing behavior for private-label vs brand-name over-the-counter products in chain pharmacies. J Pharm Mark Manag. 1994;8(1):85–108.
  • Costa-Font J, Rudisill C, Tan S. Brand loyalty, patients and limited generic medicines uptake. Health Policy. 2014;116(2):224–233.
  • Dawar N, Parker P. Marketing universals: consumers’ use of brand name, price, physical appearance, and retailer reputation as signals of product quality. J Mark. 1994;58(2):81–95.
  • Laibson D. A cue-theory of consumption*. Q J Econ. 2001;116(1):81–119.
  • Taylor JW. The role of risk in consumer behavior: a comprehensive and operational theory of risk taking in consumer behavior. J Mark. 1974;38(2):54–60.
  • Guttier M, Silveira M, Luiza V, Bertoldi A. Impact of interventions to promote the use of generic drugs: a systematic review. CiencSaudeColetiva. 2017;22(8):2627–2644.
  • Sechrest L. Validity of measures is no simple matter. Health Serv Res. 2005;40(5 Pt 2):1584–1604.
  • Morwitz VG, Steckel JH, Gupta A. When do purchase intentions predict sales? Int J Forecast. 2007;23(3):347.